Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $237.38 which represents a slight increase of $1.08 or 0.46% from the prior close of $236.3. The stock opened at $236.51 and ...

Becton, Dickinson and Company (NYSE:BDX), a leading player in the medical technology sector with a market capitalization of ...

Becton, Dickinson and Company BDX, popularly known as BD ... The optimism led by a solid fourth-quarter fiscal 2024 performance and a few strategic deals are expected to contribute further.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.17% of ...

Becton, Dickinson & Co shares are currently trading up about 1.1% on the day. The chart below shows the one year performance of BDX shares, versus its 200 day moving average: ...

Barclays analyst Matt Miksic lowered the firm’s price target on Becton Dickinson (BDX) to $278 from $312 and keeps an Overweight rating on the ...

EVP Shana Carol Neal sold 788 shares of the firm’s stock in a transaction on Tuesday, January 7th. The stock was sold at an ...

So we wouldn't blame long term Becton, Dickinson and Company (NYSE:BDX) shareholders for doubting ... have been the driver of long term performance, or if there are some discrepancies.